Should you put your hard-earned money into marijuana stocks? We detail the investment opportunities, risks, and regulations in the cannabis space.

U.S. reform of federal medical marijuana laws is giving a boost to cannabis stocks, and there appears to be more upside potential as the government also considers reclassifying recreational marijuana ...

Trulieve is the more established cannabis multi-state operator, while Vireo Growth has been growing rapidly through ...

The company filed a proxy statement with the SEC and called a meeting of stockholders to vote on a reverse stock split.

The cannabis business in the United States turned over a new leaf this year on April 22, when the U.S. Department of Justice and the U.S. Drug Enforcement Administation announced that marijuana was ...

Curaleaf CEO Jordan says institutional investors are finally engaging with cannabis. Here's why that shift - and his uplisting strategy - matter ...

Cannabis stocks jumped on April 23 when the U.S. Department of Justice announced it was reclassifying cannabis from a Schedule I to a Schedule III drug. When the smoke cleared, however, and investors ...

Canopy Growth's medical marijuana division had a great quarter, but the rest of the business wasn't so lucky.

Cannabis companies are racing the clock to list on the NYSE, as Glass House applies. A DEA hearing beginning on June 29 could catalyze the next Green Rush.

For an industry that's spent half a decade stuck in existential purgatory, this is what a revival looks like. Tilray's premarket rocket — up nearly 30% — wasn't just policy spillover. The company's ...